NATIONAL DIABETIC SCREENING PROGRAMME
Kowa Optimed has announced that its latest innovation, the Nonmyd WX 3D, has been approved for the English National Screening Programme for Diabetic Retinopathy in the UK. With over five million people expected to have diabetes in the UK by 2025, and with diabetic retinopathy being the main cause of blindness in the 16-65 year-old age group, the National Screening Programme aims to reduce the risk of sight loss by offering annual screening to diabetic patients for prompt identification and effective treatment of sight-threatening retinopathies.
www.kowa.eu/medicals
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.
AI Scribing and Telephone Management
Automating note-taking and call centres could boost practice efficiency.